Scholarlink

Objective <p>Hughes-Stovin syndrome (HSS) is a systemic vasculitis that remains an enigmatic and poorly understood clinical disorder. Despite this, no diagnostic criteria have been established since the disease was initially described in 1959. The objective of this report is to develop preliminary HSS diagnostic criteria proposed by the HSS International Study Group (HSSISG).</p> Methods <p>This international initiative included a systematic literature review of HSS case reports in a global endeavor. A systematic review of MEDLINE, EMBASE, and the Cochrane database identified 112 HSS patients. The selected reports were based on comprehensive case presentations, encompassing demographic characteristics, initial disease presentations, notable symptoms and signs, laboratory findings, radiological investigations, medical lines of treatment or interventional management received, and finally patients’ outcomes. Diagnostic criteria were selected based on their clinical relevance, dominance, and consensus among the HSSISG members. Each criterion was discussed in detail to enhance comprehension and interpretation by physicians.</p> Results <p>Following consensus agreement, one mandatory entry criterion was selected which included pulmonary findings, along with one exclusion criterion regarding ocular aspects. Two major criteria were defined, vascular aspects and coagulation profile, and four minor criteria: mucocutaneous, central nervous system, cardiac, and inflammatory markers. The maximum achievable score is 30, with a suggested definitive diagnosis of HSS with scores 10 or higher, probable HSS with scores of 5–9, and possible HSS for scores 3–4. Scores &lt; 3 are considered nondiagnostic.</p> Conclusion <p>Preliminary HSS diagnostic criteria were proposed after a comprehensive and critical literature review by the HSSISG to offer support for early diagnosis and optimal management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hughes-Stovin syndrome (HSS) preliminary diagnostic criteria: a report by the HSS International Study Group (HSSISG)

  • 期刊论文

  • 发表日期：

    2026年4月15日

查看全文
  • Yasser Emad,
  • Tamer Gheita,
  • Yasser Ragab,
  • Nevin Hammam,
  • Michael Kindermann,
  • Ossama Ibrahim,
  • Marianna Fabi,
  • Faten Frikha,
  • Khalid Alhusseiny,
  • Jasna Tekavec-Trkanjec,
  • Melek Kechida,
  • Harrison W. Farber,
  • Pablo Young,
  • Sonia Pankl,
  • Cal Robinson,
  • Samar Tharwat,
  • Aurelien Guffroy,
  • Natalia Jaramillo,
  • Nikolas Ruffer,
  • Parag Bawaskar,
  • Issam Kably,
  • Alaa Abou-Zeid,
  • Maged Hassan,
  • Sergio Ghirardo,
  • Bhupen Barman,
  • Sami Bennji,
  • Manoj Kumar Agarwala,
  • Leticia Tornes,
  • Jason Margolesky,
  • Rafael S. Silva,
  • Vitor Cruz,
  • Mohamed H. Abdelbary,
  • Jung Tae Kim,
  • Diletta Cozzi,
  • Mabrouk Abdelali,
  • Tubig C. Joy,
  • Juljani Sherwina,
  • Iman A. Kassem,
  • Farida Yasser,
  • Peter M. ten Klooster,
  • Johannes J. Rasker

摘要

Objective

Hughes-Stovin syndrome (HSS) is a systemic vasculitis that remains an enigmatic and poorly understood clinical disorder. Despite this, no diagnostic criteria have been established since the disease was initially described in 1959. The objective of this report is to develop preliminary HSS diagnostic criteria proposed by the HSS International Study Group (HSSISG).

Methods

This international initiative included a systematic literature review of HSS case reports in a global endeavor. A systematic review of MEDLINE, EMBASE, and the Cochrane database identified 112 HSS patients. The selected reports were based on comprehensive case presentations, encompassing demographic characteristics, initial disease presentations, notable symptoms and signs, laboratory findings, radiological investigations, medical lines of treatment or interventional management received, and finally patients’ outcomes. Diagnostic criteria were selected based on their clinical relevance, dominance, and consensus among the HSSISG members. Each criterion was discussed in detail to enhance comprehension and interpretation by physicians.

Results

Following consensus agreement, one mandatory entry criterion was selected which included pulmonary findings, along with one exclusion criterion regarding ocular aspects. Two major criteria were defined, vascular aspects and coagulation profile, and four minor criteria: mucocutaneous, central nervous system, cardiac, and inflammatory markers. The maximum achievable score is 30, with a suggested definitive diagnosis of HSS with scores 10 or higher, probable HSS with scores of 5–9, and possible HSS for scores 3–4. Scores < 3 are considered nondiagnostic.

Conclusion

Preliminary HSS diagnostic criteria were proposed after a comprehensive and critical literature review by the HSSISG to offer support for early diagnosis and optimal management.